Back to Search
ILA SRIVASTAVA, PHARMD
PHARMD
Pharmacist
NPI: 1952074494Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
27537(MD)
Research & Publications (20)
Heterogeneity in epoxy nanocomposites initiates crazing: significant improvements in fatigue resistance and toughening.
PMID 19296565·Small·2009
8-other
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.
PMID 19249806·Virology·2009
7-preclinical
A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide.
PMID 18835005·Virology·2008
7-preclinical
Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes.
PMID 18440102·Vaccine·2008
4-observational
Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.
PMID 18383039·Eur J Immunol·2008
7-preclinical
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.
PMID 18243435·Vaccine·2008
7-preclinical
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
PMID 18096278·Vaccine·2008
7-preclinical
Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates.
PMID 18061231·Virology·2008
4-observational
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
PMID 18195560·AIDS·2008
7-preclinical
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.
PMID 18947849·Virology·2008
7-preclinical
Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.
PMID 17707956·Vaccine·2007
7-preclinical
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens.
PMID 17560621·Virology·2007
7-preclinical
Direct inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205.
PMID 17307982·Antimicrob Agents Chemother·2007
8-other
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs.
PMID 17113201·Vaccine·2007
7-preclinical
Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
PMID 16527321·Virology·2006
7-preclinical
Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein.
PMID 17067273·AIDS Res Hum Retroviruses·2006
7-preclinical
An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains.
PMID 16940858·J Acquir Immune Defic Syndr·2006
7-preclinical
Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
PMID 16920175·Virology·2006
7-preclinical
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
PMID 16912322·J Virol·2006
4-observational
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.
PMID 16227256·J Virol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6420 MERCANTILE DR E APT 108
FREDERICK, MD 21703 - Phone
- (425) 289-6314
Quick Facts
- NPI
- 1952074494
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile